Chronic Prostatitis: Approaches for Best Management.
- Author:
Kyung Seop LEE
1
;
Jae Duck CHOI
Author Information
- Publication Type:Review
- Keywords: Chronic pelvic pain syndrome; Chronic prostatitis; Prostate
- MeSH: Anti-Bacterial Agents; Antipsychotic Agents; Humans; Pelvic Pain; Phenotype; Phytotherapy; Prostate; Prostatitis
- From:Korean Journal of Urology 2012;53(2):69-77
- CountryRepublic of Korea
- Language:English
- Abstract: Prostatitis is a prevalent condition that encompasses a large array of clinical symptoms with significant impacts on men's life. The diagnosis and treatment of this disorder presents numerous challenges for urologists, most notably, a lack of specific and effective diagnostic methods. Chronic bacterial prostatitis is successfully treated with appropriate antibiotics that penetrate the prostate and kill the causative organisms. Prostatitis category III (chronic pelvic pain syndrome) is common, very bothersome, and enigmatic. Symptoms are usually prolonged and, generally speaking, treatment results are unsatisfactory. During the last decade, research has focused on the distress caused by the condition, but although our knowledge has certainly increased, there have been no real breakthroughs; controversies and many unanswered questions remain. Furthermore, the optimal management of category III prostatitis is not known. Conventional prolonged courses of antibiotic therapy have not proven to be efficacious. Novel therapies providing some evidence for efficacy include alpha-blocker, anti-inflammatory phytotherapy, physiotherapy, neuroleptics, and others, each offering therapeutic mechanisms. A stepwise approach involving multimodal therapy is often successful for treating patients. The UPOINT technique has been used to clinically phenotype these patients and drive the appropriate selection of multimodal therapy.
